Fed. Circ. Finds Boston Scientific Patent Invalid

Law360, New York (January 15, 2009, 12:00 AM EST) -- An appeals court has reversed a decision against a Johnson & Johnson Inc. subsidiary accused of infringing a Boston Scientific Corp. patent after ruling that the stent described in the patent was an obvious invention.

In an order issued Thursday, the U.S. Court of Appeals for the Federal Circuit invalidated U.S. Patent Number 6,120,536, which covers a certain kind of drug-eluting stent and coating system used to treat patients with heart problems.

The ruling reverses a 2005 jury verdict that had found Cordis Corp., a J&J...
To view the full article, register now.